Literature DB >> 20823416

Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone.

Michele Bibas1, Susanna Grisetti, Lucia Alba, Giovanna Picchi, Franca Del Nonno, Andrea Antinori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20823416     DOI： 10.1200/JCO.2010.30.0038

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  27 in total

1.  Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs.

Authors:  Brenda De Keersmaecker; Sabine D Allard; Patrick Lacor; Rik Schots; Kris Thielemans; Joeri L Aerts
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

2.  Treatment of plasmablastic lymphoma with multiple organ involvement.

Authors:  Rong Liang; Zhe Wang; Xie-qun Chen; Qiang-xian Bai
Journal:  Singapore Med J       Date:  2014-12       Impact factor: 1.858

Review 3.  Plasmablastic lymphoma following combination treatment with fludarabine and rituximab for nongastric mucosa-associated lymphoid tissue lymphoma: a case report and review of literature.

Authors:  Jia-Zhu Wu; Ke Min; Lei Fan; Li Wang; Ji Xu; Jian-Yong Li; Wei Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.

Authors:  Yusuke Koizumi; Tomoko Uehira; Yasunori Ota; Yoshihiko Ogawa; Keishiro Yajima; Junko Tanuma; Mihoko Yotsumoto; Shotaro Hagiwara; Satoshi Ikegaya; Dai Watanabe; Hitoshi Minamiguchi; Keiko Hodohara; Kenta Murotani; Hiroshige Mikamo; Hideho Wada; Atsushi Ajisawa; Takuma Shirasaka; Hirokazu Nagai; Yoshinori Kodama; Tsunekazu Hishima; Makoto Mochizuki; Harutaka Katano; Seiji Okada
Journal:  Int J Hematol       Date:  2016-09-07       Impact factor: 2.490

Review 5.  How I treat HIV-associated lymphoma.

Authors:  Kieron Dunleavy; Wyndham H Wilson
Journal:  Blood       Date:  2012-02-15       Impact factor: 22.113

Review 6.  Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies.

Authors:  Erin G Reid
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

7.  Durable complete remission with combination chemotherapy and bortezomib in HIV-associated plasmablastic lymphoma.

Authors:  Nivedita Arora; Arjun Gupta; Navid Sadeghi
Journal:  BMJ Case Rep       Date:  2017-10-09

8.  Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.

Authors:  Ariela Noy; Shelly Y Lensing; Page C Moore; Neel Gupta; David Aboulafia; Richard Ambinder; Robert Baiocchi; Bruce J Dezube; David Henry; Lawrence Kaplan; Alexandra M Levine; Ronald Mitsuyasu; Lee Ratner; Erin Reid; Scot Remick; Joseph Sparano; Dimitrios Tzachanis; William Wachsman; Amy Chadburn
Journal:  Leuk Lymphoma       Date:  2015-12-16

9.  Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat.

Authors:  Bhagirathbhai Dholaria; Daisy Alapat; Tarun Pandey; Abhishek Agarwal
Journal:  Med Oncol       Date:  2012-05-06       Impact factor: 3.064

10.  Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: a case report and literature review.

Authors:  Ing Soo Tiong; Magreet Strauss; Michael B Y Lau; Shingirai Chiruka
Journal:  Case Rep Hematol       Date:  2013-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.